← Back to Search

Behavioral Intervention

Smoking cessation electronic visit (e-visit) for Smoking Cessation

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

Study Summary

This trial is testing an online questionnaire program to help people with COPD quit smoking. Participants will be randomly assigned to receive the program or not. The program will ask about smoking history, preferences for quitting

Who is the study for?
This trial is for current smokers aged 40 and above who smoke more than 5 cigarettes daily. Participants must be enrolled or willing to enroll in the Epic's MyChart program, have a smartphone compatible with iOS or Android for remote readings, check their email daily, speak English fluently, and have a valid mailing address.Check my eligibility
What is being tested?
The study is testing an e-visit system designed to help people quit smoking by screening for COPD symptoms and advising on cessation methods. Some participants will receive this e-visit while others won't. The study involves questionnaires and breath samples over a period of about 24 weeks.See study design
What are the potential side effects?
Since the intervention includes potential prescriptions for smoking cessation medications based on e-visits, side effects may vary depending on the medication prescribed but are not directly caused by the study's primary intervention.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in Cigarettes Per Day
Smoking Cessation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smoking cessation electronic visit (e-visit)Experimental Treatment1 Intervention
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
Group II: Treatment as usual (TAU)Active Control1 Intervention
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit
2019
N/A
~60

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
934 Previous Clinical Trials
7,394,652 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently accepting participants for this study?

"As per clinicaltrials.gov, the current status of this research indicates that it is not actively seeking participants. The trial's initial posting was on March 19, 2024, with the most recent update being on March 26, 2024. Despite this specific study not recruiting at present, there are currently 149 other trials actively looking for eligible candidates to participate in various medical investigations."

Answered by AI
~96 spots leftby Feb 2027